Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Theravance Biopharma Inc
About TBPH
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development and commercialization of medicines for the specialty respiratory and neurologic diseases. The Company operates through a single segment, namely, development and commercialization of human therapeutics. Its product, YUPELRI (revefenacin) inhalation solution, is a nebulized long-acting muscarinic antagonist used for the treatment of patients with chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that includes chronic bronchitis, emphysema, or both. YUPELRI is an anticholinergic medicine, which helps the muscles around the airway in the lungs stay relaxed to prevent symptoms, such as wheezing, shortness of breath, and others. Its Ampreloxetine, is a late-stage investigational norepinephrine reuptake inhibitor in development for the treatment of symptomatic neurogenic orthostatic hypotension in patients with Multiple System Atrophy.
Find out what a historical investment in Theravance Biopharma Inc would be worth today using our TBPH stock calculator.
Market Capitalisation
$836.19M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
556.16K
High today
$16.62
Low today
$16.21
Open price
$16.49
52-week high
$21.03
52-week low
$8.40
Ready to start your investing journey with Stake?
Open an accountHow do I buy TBPH shares in Australia?
Buying TBPH shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Theravance Biopharma Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in TBPH
What is the ticker symbol of Theravance Biopharma Inc?
The ticker symbol for Theravance Biopharma Inc is TBPH.
How much is one share of TBPH?
One share of TBPH is valued at $16.34 as of 16 May 2026.
What is the market capitalisation of Theravance Biopharma Inc TBPH?
As of 16 May 2026 Theravance Biopharma Inc has a market cap of $836.19M.
What is the P/E ratio of TBPH?
The Price to Earnings ratio of TBPH is 7.49.
What is the Earnings Per Share of TBPH?
The Earnings Per Share of TBPH is $2.20.
What is the 52-week high for Theravance Biopharma Inc stock?
The Theravance Biopharma Inc 52-week high stock price is $21.03.
What is the 52-week low for Theravance Biopharma Inc stock?
The Theravance Biopharma Inc 52-week low stock price is $8.40.
Can I buy TBPH shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy TBPH shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in TBPH on Stake
- Buy TBPH from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of TBPH from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
TBPH related stocks